Suppression of XIAP with small RNA interference technique augmented the cytotoxic effect of APO2L/TRAIL and standard chemotherapies on HCC cells, suggesting that suppression of IAPs is a novel strategy for human HCC treatment [9], [12]. This evidence concerns the gene XIAP and hepatocellular carcinoma.